List of works - John A Katzenellenbogen

A mutant form of ERα associated with estrogen insensitivity affects the coupling between ligand binding and coactivator recruitment

scientific article published on 22 September 2020

Adamantyl Antiestrogens with Novel Side Chains Reveal a Spectrum of Activities in Suppressing Estrogen Receptor Mediated Activities in Breast Cancer Cells.

scientific article published on 28 June 2017

Antagonists for Constitutively Active Mutant Estrogen Receptors: Insights into the Roles of Antiestrogen-Core and Side-Chain

scientific article published on 26 November 2018

Cyclic Ketoximes as Estrogen Receptor β Selective Agonists.

scientific article published on 2 May 2016

Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors

scientific article published on 16 August 2018

Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential.

scientific article

Exploring the Structural Compliancy versus Specificity of the Estrogen Receptor Using Isomeric Three-Dimensional Ligands.

scientific article published on 29 December 2016

Free Fatty Acids Rewire Cancer Metabolism in Obesity-Associated Breast Cancer via Estrogen Receptor and mTOR Signaling

scientific article published on 12 March 2019

Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma model

scientific article

Identification of Toll-like receptor signaling inhibitors based on selective activation of hierarchically acting signaling proteins

scientific article published on 14 August 2018

Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor beta

scientific article published on 13 February 2008

Salicylketoximes That Target Glucose Transporter 1 Restrict Energy Supply to Lung Cancer Cells

scientific article published on September 2015

Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximes.

scientific article

Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta

scientific article

Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance.

scientific article published on 16 April 2018

Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast Cancer

scientific article published on 19 September 2020

Synthesis of Anthranylaldoxime Derivatives as Estrogen Receptor Ligands and Computational Prediction of Binding Modes

scientific article published on 01 August 2006

The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells.

scientific article published on 29 November 2018

Triaryl Pyrazole Toll-Like Receptor Signaling Inhibitors: Structure-Activity Relationships Governing Pan- and Selective Signaling Inhibitors

scientific article published on 13 September 2018

List of works by John A Katzenellenbogen

A mutant form of ERα associated with estrogen insensitivity affects the coupling between ligand binding and coactivator recruitment

Adamantyl Antiestrogens with Novel Side Chains Reveal a Spectrum of Activities in Suppressing Estrogen Receptor Mediated Activities in Breast Cancer Cells.

Antagonists for Constitutively Active Mutant Estrogen Receptors: Insights into the Roles of Antiestrogen-Core and Side-Chain

Cyclic Ketoximes as Estrogen Receptor β Selective Agonists.

Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors

Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential.

Exploring the Structural Compliancy versus Specificity of the Estrogen Receptor Using Isomeric Three-Dimensional Ligands.

Free Fatty Acids Rewire Cancer Metabolism in Obesity-Associated Breast Cancer via Estrogen Receptor and mTOR Signaling

Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma model

Identification of Toll-like receptor signaling inhibitors based on selective activation of hierarchically acting signaling proteins

Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor beta

Salicylketoximes That Target Glucose Transporter 1 Restrict Energy Supply to Lung Cancer Cells

Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximes.

Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta

Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance.

Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast Cancer

Synthesis of Anthranylaldoxime Derivatives as Estrogen Receptor Ligands and Computational Prediction of Binding Modes

The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells.

Triaryl Pyrazole Toll-Like Receptor Signaling Inhibitors: Structure-Activity Relationships Governing Pan- and Selective Signaling Inhibitors